Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01221779
Other study ID # CATS01EO0801
Secondary ID
Status Recruiting
Phase Phase 2
First received October 13, 2010
Last updated August 26, 2013
Start date January 2011
Est. completion date December 2014

Study information

Verified date August 2013
Source Charite University, Berlin, Germany
Contact Marcus Meinzer, PhD
Phone +49-(0)30-450-560
Email marcus.meinzer@charite.de
Is FDA regulated No
Health authority Germany: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if non-invasive electrical brain stimulation can enhance the out of intensive language therapy in chronic aphasia


Description:

Stroke is the leading cause of death and disability worldwide. Given the increasing average lifespan worldwide, the incidence and prevalence of patients with stroke will dramatically increase in the future. One of the most frequent and devastating conditions after stroke is aphasia, which affects language production and comprehension. High-frequent intensive speech-and-language therapy is currently the treatment of choice in chronic aphasia. However, despite its general effectiveness, treatment effect sizes are only low to moderate. Thus, there is a pressing need to explore novel training-adjuvant therapies to enhance treatment efficacy. Moreover, very little is known about the neurobiology of treatment-induced recovery in chronic aphasia. This is the prerequisite to improve existing and/or develop new treatment paradigms.

Thus, in the present project we aim to assess whether the outcome of intensive language training can be enhanced by adjuvant non-invasive brain stimulation. We will be using anodal transcranial direct current stimulation (atDCS) that has previously been shown to enhance (a) language and motor learning in healthy subjects and (b) motor recovery in stroke patients. Specifically, in a longitudinal group comparison design, two matched groups of patients with chronic anomia will receive two weeks of intensive language training with or without atDCS. Treatment effects will be assessed immediately after the two week intervention period and several months after the end of the training. We will also use functional and structural magnetic resonance imaging (MRI) to elucidate language network changes in the two groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 2014
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- right-handedness

- single first time left-hemisphere stroke

- fluent- or non-fluent chronic aphasia (more than six months post-stroke)

- anomia (PR>10 and PR<60 Aachen Aphasia Naming Subtest)

- native German Speaker

Exclusion Criteria:

- more than one stroke

- alcoholism, severe psychiatric conditions, other neurological conditions

- other non-treated medical problems, severe microangiopathy

- pregnancy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Intensive language therapy
2 weeks of daily computerized naming training, daily, 3 hours
Intensive language therapy
2 weeks of daily computerized naming training, daily, 3 hours

Locations

Country Name City State
Germany Charite, University Medicine, Dept. of Neurology Berlin

Sponsors (2)

Lead Sponsor Collaborator
Charite University, Berlin, Germany German Federal Ministry of Education and Research

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Boston Naming Test Change of naming score from baseline (day 1 of study) to immediately after 2-week intervention period (post-testing) No
Secondary Boston Naming Test The follow-up will be administered to assess the stability of the treatment gains Change of naming score from post-testing (after end of intervention) to 3 months after the intervention (follow-up) No
Secondary Naming performance during functional magnetic resonance scanning assessed during overt picture naming task Change of naming score from baseline (day 1 of study) to immediately after 2-week intervention period (post-testing) No
Secondary Naming performance during functional magnetic resonance imaging assessed during overt picture naming task Change of naming score from post-testing (after end of intervention) to 3 months after the intervention (follow-up) No